Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.98 is 11% below its 5-year average of 2.22, around the middle of its 5-year range (0.42–5.28).
As of the fiscal period ended Tuesday, June 30, 2026. 28.77% above its 12-month average of 1.53.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.98.
CURRENT RATIO
1.98
CURRENT RATIO AVG TTM
1.53
CURRENT RATIO AVG 3Y
1.14
CURRENT RATIO AVG 5Y
2.22
CURRENT RATIO AVG 10Y
6.24
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+28.77%
CURRENT VS 3Y AVG
+72.99%
CURRENT VS 5Y AVG
-10.81%
CURRENT VS 10Y AVG
-68.31%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-47.31%
vs the sector median at left
Atara Biotherapeutics, Inc.
Market Cap
$85.24M
Current Ratio
1.98
TTM Avg
1.53
3Y Avg
1.14
5Y Avg
2.22
Market Cap
$85.33M
Current Ratio
7.70
TTM Avg
11.16
3Y Avg
14.97
5Y Avg
23.58
Market Cap
$84.13M
Current Ratio
7.03
TTM Avg
3.05
3Y Avg
3.90
5Y Avg
4.20
Market Cap
$83.82M
Current Ratio
16.14
TTM Avg
3.54
3Y Avg
1.85
5Y Avg
1.85
Market Cap
$87.62M
Current Ratio
4.50
TTM Avg
8.19
3Y Avg
12.95
5Y Avg
15.06
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | $85.24M | 1.98 | 1.53 | 1.14 | 2.22 |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $85.33M | 7.70 | 11.16 | 14.97 | 23.58 |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | 7.03 | 3.05 | 3.90 | 4.20 |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $83.82M | 16.14 | 3.54 | 1.85 | 1.85 |
| MediciNova, Inc. (MNOV)vs › | $83.18M | 8.75 | 11.02 | 14.04 | 18.21 |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $87.62M | 4.50 | 8.19 | 12.95 | 15.06 |
| LENSAR Inc (LNSR)vs › | $82.47M | 2.39 | 1.97 | 2.72 | 3.82 |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | 3.30 | 5.38 | 8.10 | 12.75 |
| CareCloud, Inc. (CCLD)vs › | $88.60M | 1.02 | 1.16 | 1.22 | 1.27 |
| ImmuCell Corporation (ICCC)vs › | $88.66M | 4.75 | 3.83 | 3.74 | 4.48 |
Current Ratio
1.98
Quick Ratio
1.98
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.98 |
| 2026-03-31 | 2.16 |
| 2025-12-31 | 0.82 |
| 2025-09-30 | 1.02 |
| 2025-06-30 | 1.70 |
| 2025-03-31 | 0.57 |
| 2024-12-31 | 0.48 |
| 2024-09-30 | 0.59 |
| 2024-06-30 | 0.42 |
| 2024-03-31 | 0.59 |
| 2023-12-31 | 0.72 |
| 2023-09-30 | 1.50 |
| 2023-06-30 | 2.31 |
| 2023-03-31 | 3.30 |
| 2022-12-31 | 3.74 |
| 2022-09-30 | 3.92 |
| 2022-06-30 | 5.28 |
| 2022-03-31 | 3.10 |
| 2021-12-31 | 3.64 |
| 2021-09-30 | 4.29 |
| 2021-06-30 | 4.42 |
| 2021-03-31 | 5.51 |
| 2020-12-31 | 6.31 |
| 2020-09-30 | 9.41 |
| 2020-06-30 | 11.33 |
| 2020-03-31 | 7.27 |
| 2019-12-31 | 7.43 |
| 2019-09-30 | 9.56 |
| 2019-06-30 | 7.80 |
| 2019-03-31 | 9.96 |
| 2018-12-31 | 8.04 |
| 2018-09-30 | 13.81 |
| 2018-06-30 | 15.61 |
| 2018-03-31 | 19.65 |
| 2017-12-31 | 6.23 |
| 2017-09-30 | 12.49 |
| 2017-06-30 | 19.38 |
| 2017-03-31 | 30.15 |
| 2016-12-31 | 26.93 |
| 2016-09-30 | 20.62 |
| 2016-06-30 | 29.87 |
| 2016-03-31 | 35.19 |
| 2015-12-31 | 33.43 |
| 2015-09-30 | 52.75 |
| 2015-06-30 | 13.80 |
| 2015-03-31 | 48.29 |
| 2014-12-31 | 38.92 |
| 2014-09-30 | 21.57 |
| 2014-06-30 | 27.17 |
| 2014-03-31 | 22.34 |
| 2013-12-31 | 33.99 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
